Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
life sciences
2
×
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
alder biopharmaceutical
allergan
american academy of neurology
amgen
anylam pharmaceuticals
atogepant
biohaven
biotech
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cardiomyopathy
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
indiana top stories
inotersen
jefferies
What
drug
fda
2
×
year
2
×
ago
akcea
alnylam
amyloidosis
approval
approved
arguments
attr
available
battle
big
class
commercialized
companies
competitors
debilitating
decades
disease
drugs
genetic
make
medicines
meeting
migraine
neuro
new
oks
oral
patients
pfizer
potential
rare
sets
therapies
transthyretin
won
Language
Current search:
year
×
" life sciences "
×
fda
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments